{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T14:04:25Z","timestamp":1783260265400,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02540-x","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:19:42Z","timestamp":1663917582000},"page":"1453-1458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-4837","authenticated-orcid":false,"given":"E\u015fay","family":"K\u0131ran Yenice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-547X","authenticated-orcid":false,"given":"Caner","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2540_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","volume":"62","author":"ME Hartnett","year":"2017","unstructured":"Hartnett ME (2017) Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol 62:257\u2013276. https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.004","journal-title":"Surv Ophthalmol"},{"key":"2540_CR2","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.2147\/OPTH.S324614","volume":"15","author":"R Gaber","year":"2021","unstructured":"Gaber R, Sorour OA, Sharaf AF, Saad HA (2021) Incidence and risk factors for retinopathy of prematurity (ROP) in biggest neonatal intensive care unit in Itay Elbaroud City, Behera Province. Egypt Clin Ophthalmol 15:3467\u20133471. https:\/\/doi.org\/10.2147\/OPTH.S324614","journal-title":"Egypt Clin Ophthalmol"},{"key":"2540_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/meajo.MEAJO_131_18","volume":"26","author":"B Al-Qahtani","year":"2019","unstructured":"Al-Qahtani B, Al-Otaibi M, Alabdulajabbar K, Selayem NB, Alshehri W, Omair A et al (2019) Retinopathy of prematurity incidence and risk factors in a tertiary hospital in Riyadh, Saudi Arabia. Middle East Afr J Ophthalmol 26:235\u2013239. https:\/\/doi.org\/10.4103\/meajo.MEAJO_131_18","journal-title":"Middle East Afr J Ophthalmol"},{"key":"2540_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/09286586.2018.1562082","volume":"26","author":"D Dhingra","year":"2019","unstructured":"Dhingra D, Katoch D, Dutta S, Samanta R, Aggarwal K, Dogra MR (2019) Change in the incidence and severity of retinopathy of prematurity (ROP) in a neonatal intensive care unit in Northern India after 20 years: comparison of two similar prospective cohort studies. Ophthalmic Epidemiol 26:169\u2013174. https:\/\/doi.org\/10.1080\/09286586.2018.1562082","journal-title":"Ophthalmic Epidemiol"},{"key":"2540_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S et al (2015) Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012. JAMA 314:1039\u20131051. https:\/\/doi.org\/10.1001\/jama.2015.10244","journal-title":"JAMA"},{"key":"2540_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5409\/wjcp.v5.i1.35","volume":"5","author":"PK Shah","year":"2016","unstructured":"Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N (2016) Retinopathy of prematurity: past, present and future. World J Clin Pediatr 5:35\u201346. https:\/\/doi.org\/10.5409\/wjcp.v5.i1.35","journal-title":"World J Clin Pediatr"},{"key":"2540_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/IAE.0b013e318296e26d","volume":"34","author":"J Kim","year":"2014","unstructured":"Kim J, Kim SJ, Chang YS, Park WS (2014) Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Retina 34:77\u201382. https:\/\/doi.org\/10.1097\/IAE.0b013e318296e26d","journal-title":"Retina"},{"key":"2540_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","volume":"122","author":"CK Hwang","year":"2015","unstructured":"Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR (2015) Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122:1008\u20131015. https:\/\/doi.org\/10.1016\/j.ophtha.2014.12.017","journal-title":"Ophthalmology"},{"key":"2540_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603\u2013615. https:\/\/doi.org\/10.1056\/NEJMoa1007374","journal-title":"N Engl J Med"},{"key":"2540_CR10","first-page":"233","volume":"102","author":"WV Good","year":"2004","unstructured":"Good WV (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233\u2013248","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2540_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bjo.81.1.2","volume":"81","author":"AR Fielder","year":"1997","unstructured":"Fielder AR, Quinn GE (1997) Myopia of prematurity: nature, nurture, or disease? Br J Ophthalmol 81:2\u20133. https:\/\/doi.org\/10.1136\/bjo.81.1.2","journal-title":"Br J Ophthalmol"},{"key":"2540_CR12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.ophtha.2005.03.025","volume":"112","author":"BV Davitt","year":"2005","unstructured":"Davitt BV, Dobson V, Good WV, Hardy RJ, Quinn GE, Siatkowski RM et al (2005) Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology 112:1564\u20131568. https:\/\/doi.org\/10.1016\/j.ophtha.2005.03.025","journal-title":"Ophthalmology"},{"key":"2540_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3928\/01913913-20081101-02","volume":"45","author":"A Dhawan","year":"2008","unstructured":"Dhawan A, Dogra M, Vinekar A, Gupta A, Dutta S (2008) Structural sequelae and refractive outcome after successful laser treatment for threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 45:356\u2013361. https:\/\/doi.org\/10.3928\/01913913-20081101-02","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2540_CR14","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1111\/aos.12053","volume":"91","author":"CS Yang","year":"2013","unstructured":"Yang CS, Wang AG, Shih YF, Hsu WM (2013) Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age. Acta Ophthalmol 91:e276-282. https:\/\/doi.org\/10.1111\/aos.12053","journal-title":"Acta Ophthalmol"},{"key":"2540_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.preteyeres.2017.09.002","volume":"62","author":"T Chan-Ling","year":"2018","unstructured":"Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA (2018) Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res 62:77\u2013119. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.09.002","journal-title":"Prog Retin Eye Res"},{"key":"2540_CR16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA et al (2014) Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol 132:1327\u20131333. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2772","journal-title":"JAMA Ophthalmol"},{"issue":"1119\u20131124","key":"2540_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.01.014","volume":"155","author":"BC Harder","year":"2013","unstructured":"Harder BC, Schlichtenbrede FC, von Baltz S, Jendritza W, Jendritza B, Jonas JB (2013) Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Am J Ophthalmol 155(1119\u20131124):e1111. https:\/\/doi.org\/10.1016\/j.ajo.2013.01.014","journal-title":"Am J Ophthalmol"},{"key":"2540_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5935\/0004-2749.20150079","volume":"78","author":"M Gunay","year":"2015","unstructured":"Gunay M, Celik G, Gunay BO, Aktas A, Karatekin G, Ovali F (2015) Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity. Arq Bras Oftalmol 78:300\u2013304. https:\/\/doi.org\/10.5935\/0004-2749.20150079","journal-title":"Arq Bras Oftalmol"},{"key":"2540_CR19","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10103-011-1021-z","volume":"28","author":"SK Houston","year":"2013","unstructured":"Houston SK, Wykoff CC, Berrocal AM, Hess DJ, Murray TG (2013) Laser treatment for retinopathy of prematurity. Lasers Med Sci 28:683\u2013692. https:\/\/doi.org\/10.1007\/s10103-011-1021-z","journal-title":"Lasers Med Sci"},{"key":"2540_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ophtha.2021.05.031","volume":"128","author":"MF Chiang","year":"2021","unstructured":"Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A et al (2021) International classification of retinopathy of prematurity, third edition. Ophthalmology 128:51\u201368. https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.031","journal-title":"Ophthalmology"},{"key":"2540_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/0301-4738.86306","volume":"59","author":"D Katoch","year":"2011","unstructured":"Katoch D, Sanghi G, Dogra MR, Beke N, Gupta A (2011) Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes. Indian J Ophthalmol 59:423\u2013426. https:\/\/doi.org\/10.4103\/0301-4738.86306","journal-title":"Indian J Ophthalmol"},{"key":"2540_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00417-020-04946-8","volume":"259","author":"T Inoue","year":"2021","unstructured":"Inoue T, Asaoka R, Hashimoto Y, Kitamoto K, Kitano M, Fujita A et al (2021) Does the number of laser applications for ROP treatment influence the degree of myopia? Graefes Arch Clin Exp Ophthalmol 259:317\u2013322. https:\/\/doi.org\/10.1007\/s00417-020-04946-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2540_CR23","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41433-020-01321-z","volume":"35","author":"Y Mori","year":"2021","unstructured":"Mori Y, Arima M, Ueda E, Fujiwara K, Seki E, Nakama T et al (2021) Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity. Eye (Lond) 35:2820\u20132825. https:\/\/doi.org\/10.1038\/s41433-020-01321-z","journal-title":"Eye (Lond)"},{"key":"2540_CR24","first-page":"26","volume":"9","author":"PM Pennefather","year":"1995","unstructured":"Pennefather PM, Clarke MP, Strong NP, Cottrell DG, Fritz S, Tin W (1995) Ocular outcome in children born before 32 weeks gestation. Eye (Lond) 9:26\u201330","journal-title":"Eye (Lond)"},{"key":"2540_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10792-016-0439-5","volume":"38","author":"JYC Lok","year":"2018","unstructured":"Lok JYC, Yip WWK, Luk ASW, Chin JKY, Lau HHW, Young AL (2018) Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong. Int Ophthalmol 38:163\u2013169. https:\/\/doi.org\/10.1007\/s10792-016-0439-5","journal-title":"Int Ophthalmol"},{"key":"2540_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12886-021-02172-2","volume":"21","author":"L Huo","year":"2021","unstructured":"Huo L, Qi Y, Zhao S (2021) Refractive errors and risk factors for myopia in infants aged 1\u201318 months in Tianjin. China BMC Ophthalmol 21:403. https:\/\/doi.org\/10.1186\/s12886-021-02172-2","journal-title":"China BMC Ophthalmol"},{"key":"2540_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004469","volume":"4","author":"RM Varghese","year":"2009","unstructured":"Varghese RM, Sreenivas V, Puliyel JM, Varughese S (2009) Refractive status at birth: its relation to newborn physical parameters at birth and gestational age. PLoS ONE 4:e4469. https:\/\/doi.org\/10.1371\/journal.pone.0004469","journal-title":"PLoS ONE"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02540-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02540-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02540-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T15:04:28Z","timestamp":1682867068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02540-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2540"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02540-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no relevant financial or non-financial interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Health Science (2022\/06)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}